Collectively, our data show that the mouse model with absence of FPR-1 gene displayed reduced inflammation after 4-week CS exposure, which may in part through the regulation of NF-κB, suggesting it as a new target to control the CS-induced airway inflammation in COPD. The gene discussed is FPR1; the disease is chronic obstructive pulmonary disease.